Cost-effectiveness Analysis of TCM Injection in Adjuvant Treatment of Coronary Heart Disease with Heart Failure / 中国药房
China Pharmacy
;
(12): 3614-3616, 2015.
Article
Dans Chinois
| WPRIM
| ID: wpr-502643
ABSTRACT
OBJECTIVE:
To evaluate the cost and effectiveness of Shenmai injection and Salvianolate for injection in adjuvant treatment of coronary heart disease with heart failure.METHODS:
In prospective randomized controlled clinical study,103 pa-tients with coronary heart disease with heart failure were randomized into 2 groups55 patients in group A received Shenmai injec-tion 50 ml added into 5% Glucose solution 250 ml intravenously on the basis of routine treatment,once a day;48 patients in group B received Salvianolate for injection 200 mg added into 5% Glucose solution 250 ml intravenously on the basis of routine treatment,once a day;treatment course lasted for 2 weeks. The improvement of clinical indicators and ADR were observed before and after treatment;2 drug treatment programs were evaluated and analyzed with pharmacoeconomics.RESULTS:
Total effective rates of group A and B were 89.09% and 72.92%,with statistical significance(P0.05). The cost-effectiveness ratio of group A was significantly lower than that of group B,with statistical significance(P<0.05);the results of sensitivity analysis was consistent with it,indicat-ing the cost of Shenmai injection was in low level.CONCLUSIONS:
Shenmai injection is more economic in adjuvant treatment of coronary heart disease with heart failure.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Essai clinique contrôlé
/
Évaluation en économique de la santé
langue:
Chinois
Texte intégral:
China Pharmacy
Année:
2015
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS